The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
Australian scientists find that ivermectin (common wormer) used in the laboratory in vitro kills coronavirus within 48-hours; next step will be human trials
Highlights
• Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2) in vitro.
• A single treatment able to effect ∼5000-fold reduction in virus at 48h in cell culture.
• Ivermectin is FDA-approved for parasitic infections, and therefore has a potential for repurposing.
• Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines.
Full report attached